ABEO·00289Y206·US·equity·Healthcare - Biotechnology-13D/G
ABEO (Abeona Therapeutics Inc.) is held by 62 institutional investors as of Q4 2025. Largest holders: BlackRock, Inc. ($16.7M), VANGUARD GROUP INC ($14.5M), GEODE CAPITAL MANAGEMENT, LLC ($6M). Net institutional sentiment: Mixed.
See how ABEO's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer